PSMB1 and plasma cell myeloma: In addition, PSMB1 was shown to affect the response of follicular lymphoma to bortezomib and that the presence of the PSMB1 rs12717 minor allele predicted the ineffectiveness of bortezomib in patients with myeloma (45).